EIR Amphastar Pharmaceuticals Feb 2013

Binh Nguyen FDA$595.00 - Available Now

FDA investigators audited the Amphastar Pharmaceuticals - Rancho Cucamonga, CA, United States facility and issued inspectional observation (via FDA 483) on 06 Feb 2013.

Product details

  • Category:
  • Inspection end: 06 Feb 2013
  • Location: Rancho Cucamonga, United States
  • FEI: 3002936358
Add To Cart